ivx-a12
·Code: IVX-A12, IVX-121, IVX-241
ivx-a12: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Icosavax, Inc. (ICVX) | Phase 2 |
Clinical Trials (1)
A Phase 2, Randomized, Modified Double-Blind, Active Controlled Study to Characterize the Safety and Immunogenicity of IVX-A12 in Adults 60 Years of Age and Older
Frequently asked questions
Who is developing ivx-a12?
ivx-a12 is being developed by Icosavax, Inc..
How many clinical trials involve ivx-a12?
BioSniper tracks 1 clinical trial involving ivx-a12.
Get deeper analysis on ivx-a12
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis